Director: David A. Schwartz, M.D.
The Vanderbilt Inflammatory Bowel Disease (IBD) Center treats patients with ulcerative colitis and Crohn’s disease – the two primary diseases associated with inflammatory bowel. Nearly 2 million Americans are affected by these diseases, which are highly disruptive to daily functioning and cause both physical and psychological distress.
Ulcerative colitis and Crohn’s are similar in many ways and are often mistaken for each other. Making an accurate diagnosis is important so that an individual can receive the most effective treatment for his or her disease. The gastroenterologists, colorectal surgeons, nurses, psychologists and nutritionists in the IBD Center work together to provide individualized comprehensive assessment and treatment plans. Utilizing the latest diagnostic procedures and treatment options, they address the patient’s ongoing physical, nutritional and psychosocial needs.
The Vanderbilt IBD Center is a member of the Crohn’s and Colitis Foundation of America (CCFA) clinical research alliance, a group of 70 medical centers testing new drug therapies for ulcerative colitis and Crohn’s disease.